patent on semaglutide Massive Rs 50,000 Cr Opportunity for Drugmakers as Patents Expire, ETPharma India Obesity Crisis: The Expiry

It launched in India in December 2025

Supplementing with hydrolyzed collagen peptides and applying copper peptides topically are popular because of their many health benefits

Semaglutide, on the other hand, has been shown to improve cardiovascular outcomes in people with type 2 diabetes and obesity, helping to lower the risk of heart disease and related events

10.1111/jcmm.15904 132 NiZ.TaoL.XiaohuiX.ZelinZ.JiangangL.ZhaoS.et al (2017)

8-oxo-dG, 8-Oxo-2-deoxyguanosine

In recent years, GLP-1 receptor agonists have revolutionized the field of obesity medicine, providing science-backed support for accelerated weight loss